Theresa Boni - 01 Apr 2022 Form 4 Insider Report for Surface Oncology, Inc.

Role
General Counsel & Secretary
Signature
/s/ Robert Ross, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
01 Apr 2022, 20:00:25 UTC
Previous filing
18 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 01 Apr 2022 Common Stock 120,000 $2.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the Options shall vest on March 14, 2023, and the remainder of the Options shall vest in equal monthly installments over the following three-year period, such that all of the Options shall be vested on March 14, 2026, subject to the Reporting Person's continued service relationship with the Company on each such vesting date.